精彩内容近期,集采消息频传:第三批中成药集采全国落地,新疆26省联盟集采报量在即,浙江拟启动第六批药品集采;江苏44个品种接续集采来袭,不乏桉柠蒎口服常释剂型等独家大单品(含剂型独家,下同),以及亮丙瑞林(缓释)微球注射剂等2024年在江苏省公立医院终端销售额超1亿元的临床畅销药。2025年过近半,第十一批国采如箭在弦,拟纳入品种目录有望于近日出炉;省采/省联采稳步推进,安徽、四川、新疆等地先后...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.